Cargando…
Chronic Dexamethasone Treatment Leads to Less Weight Gain and Ameliorated Glucose Tolerance in Mice; Role of the Cytoprotective Nrf2 Pathway
Introduction: Chronic glucocorticoid administration is necessary in a variety of conditions including but not limited to autoimmune, inflammatory and cancer-related diseases in order to relieve symptoms and sustain disease progression. However, there are adverse effects that include increase in gluc...
Autores principales: | Filippopoulou, Fotini, Douni, Eleni, Sophocleus, Antonia, Habeos, Ioannis, Chartoumpekis, Dionysios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089894/ http://dx.doi.org/10.1210/jendso/bvab048.1640 |
Ejemplares similares
-
Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2
por: Filippopoulou, Fotini, et al.
Publicado: (2021) -
Mapping of Corticosteroids in Murine Kidneys Using Mass Spectrometry Imaging
por: Stasinopoulos, Ioannis, et al.
Publicado: (2021) -
SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies
por: Snaterse, Gido, et al.
Publicado: (2019) -
SAT-LB001 Traditional Sex Steroids and Ketoandrogen Levels by Menstrual Cycle Stage, Age and Body Mass Index in Women Aged 18-39 Years
por: Skiba, Marina, et al.
Publicado: (2019) -
SAT-001 Supra-Physiological Testosterone Treatment Reduces Aortic Atheroma but Increases Markers of Cardiac Hypertrophy
por: Kelly, Daniel, et al.
Publicado: (2019)